Associated Papers
Distinct mutation profiles between primary bladder cancer and circulating tumor cells warrant the use of circulating tumors cells as cellular resource for mutation follow-up.
Kim TM et al.
Bmc Cancer, 2020
33287735 (PubMed )
Supplement: 12885_2020_7684_MOESM2_ESM.xlsx › Sheet1
Integrated clinical, whole-genome, and transcriptome analysis of multisampled lethal metastatic prostate cancer.
Bova GS et al.
Cold Spring Harbor Molecular Case Studies, 2016
27148588 (PubMed )
Supplement: supp_mcs.a000752_SuppTable2.xls › Sheet_1
Select a paper to view details